第99.1展示文本 |
投資者聯繫方式 | 媒體聯繫人 | ||||
Brent Collins | Rick Axthelm | ||||
副總裁,財務主管及投資者關係 | 首席公共事務和可持續發展官 | ||||
+1.913.344.9111 | +1.913.344.9198 | ||||
InvestorRelations@compassminerals.com | MediaRelations@compassminerals.com |
Special Items Impacting the Three Months Ended June 30, 2024 (unaudited, in millions, except per share data) | ||||||||||||||||||||||||||||||||||||||
Item Description | Segment | Line Item | Amount | Tax Effect(1) | After Tax | EPS Impact | ||||||||||||||||||||||||||||||||
Restructuring charges(2) | Corporate and Other | Other operating expense | $ | 1.5 | $ | — | $ | 1.5 | $ | 0.04 | ||||||||||||||||||||||||||||
Total | $ | 1.5 | $ | — | $ | 1.5 | $ | 0.04 |
Special Items Impacting the Nine Months Ended June 30, 2024 (unaudited, in millions, except per share data) | ||||||||||||||||||||||||||||||||||||||
Item Description | Segment | Line Item | Amount | Tax Effect(1) | After Tax | EPS Impact | ||||||||||||||||||||||||||||||||
Restructuring charges(2) | Corporate and Other | Other operating expense | $ | 16.2 | $ | — | $ | 16.2 | $ | 0.39 | ||||||||||||||||||||||||||||
Restructuring charges(2) | Salt | COGS and Other operating expense | 0.4 | — | 0.4 | 0.01 | ||||||||||||||||||||||||||||||||
Restructuring charges(2) | Plant Nutrition | COGS and Other operating expense | 0.6 | — | 0.6 | 0.01 | ||||||||||||||||||||||||||||||||
Impairments | Corporate and Other | COGS and Loss on impairments | 124.8 | — | 124.8 | 3.02 | ||||||||||||||||||||||||||||||||
Goodwill impairment | Plant Nutrition | Loss on impairments | 51.0 | — | 51.0 | 1.23 | ||||||||||||||||||||||||||||||||
Total | $ | 193.0 | $ | — | $ | 193.0 | $ | 4.66 |
Reconciliation for Adjusted Operating Earnings (unaudited, in millions) | |||||||||||||||||||||||
Three Months Ended June 30, | Nine Months Ended June 30, | ||||||||||||||||||||||
2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||
Operating earnings (loss) | $ | 5.9 | $ | (0.6) | $ | (87.0) | $ | 75.2 | |||||||||||||||
Restructuring charges(1) | 1.5 | 2.2 | 17.2 | 5.5 | |||||||||||||||||||
Loss on impairments(2) | — | — | 175.8 | — | |||||||||||||||||||
Accrued loss and legal costs related to SEC investigation(3) | — | — | — | (0.1) | |||||||||||||||||||
Adjusted operating earnings | $ | 7.4 | $ | 1.6 | $ | 106.0 | $ | 80.6 | |||||||||||||||
Sales | 202.9 | 207.6 | 908.6 | 971.1 | |||||||||||||||||||
Operating margin | 2.9 | % | (0.3) | % | (9.6) | % | 7.7 | % | |||||||||||||||
Adjusted operating margin | 3.6 | % | 0.8 | % | 11.7 | % | 8.3 | % |
Reconciliation for Adjusted Net (Loss) Earnings (unaudited, in millions) | |||||||||||||||||||||||
Three Months Ended June 30, | Nine Months Ended June 30, | ||||||||||||||||||||||
2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||
Net (loss) earnings | $ | (43.6) | $ | 36.4 | $ | (157.8) | $ | 14.5 | |||||||||||||||
Restructuring charges(1) | 1.5 | 2.1 | 17.2 | 5.4 | |||||||||||||||||||
Loss on impairments(2) | — | — | 175.8 | — | |||||||||||||||||||
Accrued loss and legal costs related to SEC investigation(3) | — | — | — | (0.1) | |||||||||||||||||||
Adjusted net (loss) earnings | $ | (42.1) | $ | 38.5 | $ | 35.2 | $ | 19.8 | |||||||||||||||
Net (loss) earnings per diluted share | $ | (1.05) | $ | 0.88 | $ | (3.83) | $ | 0.35 | |||||||||||||||
Adjusted net (loss) earnings per diluted share | $ | (1.01) | $ | 0.93 | $ | 0.83 | $ | 0.48 | |||||||||||||||
Weighted-average common shares outstanding (in thousands): | |||||||||||||||||||||||
Diluted | 41,342 | 41,142 | 41,284 | 40,663 |
Reconciliation for EBITDA and Adjusted EBITDA (unaudited, in millions) | |||||||||||||||||||||||
Three Months Ended June 30, | Nine Months Ended June 30, | ||||||||||||||||||||||
2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||
Net (loss) earnings | $ | (43.6) | $ | 36.4 | $ | (157.8) | $ | 14.5 | |||||||||||||||
Interest expense | 17.2 | 14.3 | 50.4 | 42.4 | |||||||||||||||||||
Income tax expense (benefit) | 32.7 | (42.8) | 20.4 | 24.2 | |||||||||||||||||||
Depreciation, depletion and amortization | 26.1 | 24.3 | 78.4 | 72.7 | |||||||||||||||||||
EBITDA | 32.4 | 32.2 | (8.6) | 153.8 | |||||||||||||||||||
Adjustments to EBITDA: | |||||||||||||||||||||||
Stock-based compensation - non-cash | (0.7) | 3.5 | 6.3 | 17.2 | |||||||||||||||||||
Interest income | (0.2) | (1.7) | (0.8) | (4.7) | |||||||||||||||||||
(Gain) loss on foreign exchange | (0.5) | 2.3 | (1.1) | 4.6 | |||||||||||||||||||
Gain from remeasurement of equity method investment | — | (12.6) | — | (12.6) | |||||||||||||||||||
Restructuring charges(1) | 1.5 | 2.2 | 17.2 | 5.9 | |||||||||||||||||||
Loss on impairments(2) | — | — | 175.8 | — | |||||||||||||||||||
Accrued loss and legal costs related to SEC investigation(3) | — | — | — | (0.1) | |||||||||||||||||||
Other expense, net | 0.3 | 2.7 | 1.9 | 3.7 | |||||||||||||||||||
Adjusted EBITDA | $ | 32.8 | $ | 28.6 | $ | 190.7 | $ | 167.8 | |||||||||||||||
Salt Segment Performance (unaudited, in millions, except for sales volumes and prices per short ton) | |||||||||||||||||||||||
Three Months Ended June 30, | Nine Months Ended June 30, | ||||||||||||||||||||||
2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||
Sales | $ | 160.6 | $ | 155.5 | $ | 745.3 | $ | 824.1 | |||||||||||||||
Operating earnings | $ | 25.9 | $ | 21.7 | $ | 142.6 | $ | 141.9 | |||||||||||||||
Operating margin | 16.1 | % | 14.0 | % | 19.1 | % | 17.2 | % | |||||||||||||||
Adjusted operating earnings(1) | $ | 25.9 | $ | 22.2 | $ | 143.0 | $ | 143.4 | |||||||||||||||
Adjusted operating margin(1) | 16.1 | % | 14.3 | % | 19.2 | % | 17.4 | % | |||||||||||||||
EBITDA(1) | $ | 41.6 | $ | 35.9 | $ | 189.7 | $ | 184.8 | |||||||||||||||
EBITDA(1) margin | 25.9 | % | 23.1 | % | 25.5 | % | 22.4 | % | |||||||||||||||
Adjusted EBITDA(1) | $ | 41.6 | $ | 36.4 | $ | 190.1 | $ | 186.3 | |||||||||||||||
Adjusted EBITDA(1) margin | 25.9 | % | 23.4 | % | 25.5 | % | 22.6 | % | |||||||||||||||
Sales volumes (in thousands of tons): | |||||||||||||||||||||||
Highway deicing | 1,090 | 1,070 | 6,401 | 7,886 | |||||||||||||||||||
Consumer and industrial | 393 | 421 | 1,403 | 1,529 | |||||||||||||||||||
Total Salt | 1,483 | 1,491 | 7,804 | 9,415 | |||||||||||||||||||
Average prices (per ton): | |||||||||||||||||||||||
Highway deicing | $ | 77.20 | $ | 73.86 | $ | 73.60 | $ | 68.86 | |||||||||||||||
Consumer and industrial | $ | 194.35 | $ | 181.66 | $ | 195.37 | $ | 183.81 | |||||||||||||||
Total Salt | $ | 108.27 | $ | 104.28 | $ | 95.50 | $ | 87.53 |
Reconciliation for Salt Segment Adjusted Operating Earnings (unaudited, in millions) | |||||||||||||||||||||||
Three Months Ended June 30, | Nine Months Ended June 30, | ||||||||||||||||||||||
2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||
Reported GAAP segment operating earnings | $ | 25.9 | $ | 21.7 | $ | 142.6 | $ | 141.9 | |||||||||||||||
Restructuring charges(1) | — | 0.5 | 0.4 | 1.5 | |||||||||||||||||||
Segment adjusted operating earnings | $ | 25.9 | $ | 22.2 | $ | 143.0 | $ | 143.4 | |||||||||||||||
Segment sales | 160.6 | 155.5 | 745.3 | 824.1 | |||||||||||||||||||
Segment operating margin | 16.1 | % | 14.0 | % | 19.1 | % | 17.2 | % | |||||||||||||||
Segment adjusted operating margin | 16.1 | % | 14.3 | % | 19.2 | % | 17.4 | % |
Reconciliation for Salt Segment EBITDA and Adjusted EBITDA (unaudited, in millions) | |||||||||||||||||||||||
Three Months Ended June 30, | Nine Months Ended June 30, | ||||||||||||||||||||||
2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||
Reported GAAP segment operating earnings | $ | 25.9 | $ | 21.7 | $ | 142.6 | $ | 141.9 | |||||||||||||||
Depreciation, depletion and amortization | 15.7 | 14.2 | 47.1 | 42.9 | |||||||||||||||||||
Segment EBITDA | $ | 41.6 | $ | 35.9 | $ | 189.7 | $ | 184.8 | |||||||||||||||
Restructuring charges(1) | — | 0.5 | 0.4 | 1.5 | |||||||||||||||||||
Segment adjusted EBITDA | $ | 41.6 | $ | 36.4 | $ | 190.1 | $ | 186.3 | |||||||||||||||
Segment sales | 160.6 | 155.5 | 745.3 | 824.1 | |||||||||||||||||||
Segment EBITDA margin | 25.9 | % | 23.1 | % | 25.5 | % | 22.4 | % | |||||||||||||||
Segment adjusted EBITDA margin | 25.9 | % | 23.4 | % | 25.5 | % | 22.6 | % |
Plant Nutrition Segment Performance (unaudited, dollars in millions, except for sales volumes and prices per short ton) | |||||||||||||||||||||||
Three Months Ended June 30, | Nine Months Ended June 30, | ||||||||||||||||||||||
2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||
Sales | $ | 38.8 | $ | 47.5 | $ | 138.6 | $ | 136.8 | |||||||||||||||
Operating (loss) earnings | $ | (1.4) | $ | 2.5 | $ | (56.7) | $ | 12.8 | |||||||||||||||
Operating margin | (3.6) | % | 5.3 | % | (40.9) | % | 9.4 | % | |||||||||||||||
Adjusted operating (loss) earnings(1) | $ | (1.4) | $ | 3.5 | $ | (5.1) | $ | 14.2 | |||||||||||||||
Adjusted operating margin(1) | (3.6) | % | 7.4 | % | (3.7) | % | 10.4 | % | |||||||||||||||
EBITDA(1) | $ | 7.2 | $ | 10.7 | $ | (31.0) | $ | 37.4 | |||||||||||||||
EBITDA(1) margin | 18.6 | % | 22.5 | % | (22.4) | % | 27.3 | % | |||||||||||||||
Adjusted EBITDA(1) | $ | 7.2 | $ | 11.7 | $ | 20.6 | $ | 38.8 | |||||||||||||||
Adjusted EBITDA(1) margin | 18.6 | % | 24.6 | % | 14.9 | % | 28.4 | % | |||||||||||||||
Sales volumes (in thousands of tons) | 56 | 63 | 205 | 168 | |||||||||||||||||||
Average price (per ton) | $ | 691.27 | $ | 751.58 | $ | 676.11 | $ | 813.56 |
Reconciliation for Plant Nutrition Segment Adjusted Operating (Loss) Earnings (unaudited, in millions) | |||||||||||||||||||||||
Three Months Ended June 30, | Nine Months Ended June 30, | ||||||||||||||||||||||
2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||
Reported GAAP segment operating (loss) earnings | $ | (1.4) | $ | 2.5 | $ | (56.7) | $ | 12.8 | |||||||||||||||
Restructuring charges(1) | — | 1.0 | 0.6 | 1.4 | |||||||||||||||||||
Loss on goodwill impairment(2) | — | — | 51.0 | — | |||||||||||||||||||
Segment adjusted operating (loss) earnings | $ | (1.4) | $ | 3.5 | $ | (5.1) | $ | 14.2 | |||||||||||||||
Segment sales | 38.8 | 47.5 | 138.6 | 136.8 | |||||||||||||||||||
Segment operating margin | (3.6) | % | 5.3 | % | (40.9) | % | 9.4 | % | |||||||||||||||
Segment adjusted operating margin | (3.6) | % | 7.4 | % | (3.7) | % | 10.4 | % |
Reconciliation for Plant Nutrition Segment EBITDA and Adjusted EBITDA (unaudited, in millions) | |||||||||||||||||||||||
Three Months Ended June 30, | Nine Months Ended June 30, | ||||||||||||||||||||||
2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||
Reported GAAP segment operating (loss) earnings | $ | (1.4) | $ | 2.5 | $ | (56.7) | $ | 12.8 | |||||||||||||||
Depreciation, depletion and amortization | 8.6 | 8.2 | 25.7 | 24.6 | |||||||||||||||||||
Segment EBITDA | $ | 7.2 | $ | 10.7 | $ | (31.0) | $ | 37.4 | |||||||||||||||
Restructuring charges(1) | — | 1.0 | 0.6 | 1.4 | |||||||||||||||||||
Loss on goodwill impairment(2) | — | — | 51.0 | — | |||||||||||||||||||
Segment adjusted EBITDA | $ | 7.2 | $ | 11.7 | $ | 20.6 | $ | 38.8 | |||||||||||||||
Segment sales | 38.8 | 47.5 | 138.6 | 136.8 | |||||||||||||||||||
Segment EBITDA margin | 18.6 | % | 22.5 | % | (22.4) | % | 27.3 | % | |||||||||||||||
Segment adjusted EBITDA margin | 18.6 | % | 24.6 | % | 14.9 | % | 28.4 | % |
Three Months Ended June 30, | Nine Months Ended June 30, | ||||||||||||||||||||||
2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||
Sales | $ | 202.9 | $ | 207.6 | $ | 908.6 | $ | 971.1 | |||||||||||||||
Shipping and handling cost | 53.2 | 53.8 | 255.1 | 291.3 | |||||||||||||||||||
Product cost | 117.1 | 119.2 | 478.0 | 490.0 | |||||||||||||||||||
Gross profit | 32.6 | 34.6 | 175.5 | 189.8 | |||||||||||||||||||
Selling, general and administrative expenses | 27.5 | 33.0 | 106.5 | 109.2 | |||||||||||||||||||
Loss on impairments | — | — | 173.4 | — | |||||||||||||||||||
Other operating (income) expense | (0.8) | 2.2 | (17.4) | 5.4 | |||||||||||||||||||
Operating earnings (loss) | 5.9 | (0.6) | (87.0) | 75.2 | |||||||||||||||||||
Other (income) expense: | |||||||||||||||||||||||
Interest income | (0.2) | (1.7) | (0.8) | (4.7) | |||||||||||||||||||
Interest expense | 17.2 | 14.3 | 50.4 | 42.4 | |||||||||||||||||||
(Gain) loss on foreign exchange | (0.5) | 2.3 | (1.1) | 4.6 | |||||||||||||||||||
Net loss in equity investee | — | 0.8 | — | 3.1 | |||||||||||||||||||
Gain from remeasurement of equity method investment | — | (12.6) | — | (12.6) | |||||||||||||||||||
Other expense, net | 0.3 | 2.7 | 1.9 | 3.7 | |||||||||||||||||||
(Loss) earnings before income taxes | (10.9) | (6.4) | (137.4) | 38.7 | |||||||||||||||||||
Income tax expense (benefit) | 32.7 | (42.8) | 20.4 | 24.2 | |||||||||||||||||||
Net (loss) earnings | $ | (43.6) | $ | 36.4 | $ | (157.8) | $ | 14.5 | |||||||||||||||
Basic net (loss) earnings per common share | $ | (1.05) | $ | 0.88 | $ | (3.83) | $ | 0.35 | |||||||||||||||
Diluted net (loss) earnings per common share | $ | (1.05) | $ | 0.88 | $ | (3.83) | $ | 0.35 | |||||||||||||||
Weighted-average common shares outstanding (in thousands):(1) | |||||||||||||||||||||||
Basic | 41,342 | 41,142 | 41,284 | 40,663 | |||||||||||||||||||
Diluted | 41,342 | 41,142 | 41,284 | 40,663 |
June 30, | Sept. 30, | ||||||||||
2024 | 2023 | ||||||||||
ASSETS | |||||||||||
Cash and cash equivalents | $ | 12.8 | $ | 38.7 | |||||||
Receivables, net | 92.3 | 129.3 | |||||||||
Inventories | 407.5 | 399.5 | |||||||||
Other current assets | 34.4 | 33.4 | |||||||||
Property, plant and equipment, net | 787.9 | 852.5 | |||||||||
Intangible and other noncurrent assets | 260.3 | 363.5 | |||||||||
Total assets | $ | 1,595.2 | $ | 1,816.9 | |||||||
LIABILITIES AND STOCKHOLDERS' EQUITY | |||||||||||
Current portion of long-term debt | $ | 6.3 | $ | 5.0 | |||||||
Other current liabilities | 182.1 | 269.6 | |||||||||
Long-term debt, net of current portion | 868.8 | 800.3 | |||||||||
Deferred income taxes and other noncurrent liabilities | 185.9 | 221.0 | |||||||||
Total stockholders' equity | 352.1 | 521.0 | |||||||||
Total liabilities and stockholders' equity | $ | 1,595.2 | $ | 1,816.9 |
COMPASS MINERALS INTERNATIONAL, INC. | |||||||||||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | |||||||||||
(unaudited, in millions) | |||||||||||
Nine Months Ended June 30, | |||||||||||
2024 | 2023 | ||||||||||
Net cash provided by operating activities | $ | 27.1 | $ | 126.9 | |||||||
Cash flows from investing activities: | |||||||||||
Capital expenditures | (93.3) | (84.5) | |||||||||
Acquisition of business, net of cash acquired | — | (18.9) | |||||||||
Other, net | (1.7) | (2.5) | |||||||||
Net cash used in investing activities | (95.0) | (105.9) | |||||||||
Cash flows from financing activities: | |||||||||||
Proceeds from revolving credit facility borrowings | 359.6 | 66.7 | |||||||||
Principal payments on revolving credit facility borrowings | (289.2) | (218.2) | |||||||||
Proceeds from issuance of long-term debt | 69.4 | 237.5 | |||||||||
Principal payments on long-term debt | (70.3) | (311.7) | |||||||||
Payments for contingent consideration | (9.1) | — | |||||||||
Net proceeds from private placement of common stock | — | 240.7 | |||||||||
Dividends paid | (12.7) | (18.7) | |||||||||
Deferred financing costs | (2.1) | (3.9) | |||||||||
Shares withheld to satisfy employee tax obligations | (2.0) | (1.6) | |||||||||
Other, net | (1.4) | (0.9) | |||||||||
Net cash provided by (used in) financing activities | 42.2 | (10.1) | |||||||||
Effect of exchange rate changes on cash and cash equivalents | (0.2) | 1.0 | |||||||||
Net change in cash and cash equivalents | (25.9) | 11.9 | |||||||||
Cash and cash equivalents, beginning of the year | 38.7 | 46.1 | |||||||||
Cash and cash equivalents, end of period | $ | 12.8 | $ | 58.0 | |||||||
Three Months Ended June 30, 2024 | Salt | Plant Nutrition | Corporate & Other(1) | Total | ||||||||||||||||||||||
Sales to external customers | $ | 160.6 | $ | 38.8 | $ | 3.5 | $ | 202.9 | ||||||||||||||||||
Intersegment sales | — | 2.8 | (2.8) | — | ||||||||||||||||||||||
Shipping and handling cost | 48.2 | 5.0 | — | 53.2 | ||||||||||||||||||||||
Operating earnings (loss)(2)(3) | 25.9 | (1.4) | (18.6) | 5.9 | ||||||||||||||||||||||
Depreciation, depletion and amortization | 15.7 | 8.6 | 1.8 | 26.1 | ||||||||||||||||||||||
Total assets (as of end of period) | 1,013.3 | 408.1 | 173.8 | 1,595.2 |
Three Months Ended June 30, 2023 | Salt | Plant Nutrition | Corporate & Other(1) | Total | ||||||||||||||||||||||
Sales to external customers | $ | 155.5 | $ | 47.5 | $ | 4.6 | $ | 207.6 | ||||||||||||||||||
Intersegment sales | — | 2.8 | (2.8) | — | ||||||||||||||||||||||
Shipping and handling cost | 48.2 | 5.6 | — | 53.8 | ||||||||||||||||||||||
Operating earnings (loss)(3) | 21.7 | 2.5 | (24.8) | (0.6) | ||||||||||||||||||||||
Depreciation, depletion and amortization | 14.2 | 8.2 | 1.9 | 24.3 | ||||||||||||||||||||||
Total assets (as of end of period) | 970.1 | 477.1 | 286.3 | 1,733.5 |
Nine Months Ended June 30, 2024 | Salt | Plant Nutrition | Corporate & Other(1) | Total | ||||||||||||||||||||||
Sales to external customers | $ | 745.3 | $ | 138.6 | $ | 24.7 | $ | 908.6 | ||||||||||||||||||
Intersegment sales | — | 6.6 | (6.6) | — | ||||||||||||||||||||||
Shipping and handling cost | 235.9 | 18.6 | 0.6 | 255.1 | ||||||||||||||||||||||
Operating earnings (loss)(2)(3)(4) | 142.6 | (56.7) | (172.9) | (87.0) | ||||||||||||||||||||||
Depreciation, depletion and amortization | 47.1 | 25.7 | 5.6 | 78.4 |
Nine Months Ended June 30, 2023 | Salt | Plant Nutrition | Corporate & Other(1) | Total | ||||||||||||||||||||||
Sales to external customers | $ | 824.1 | $ | 136.8 | $ | 10.2 | $ | 971.1 | ||||||||||||||||||
Intersegment sales | — | 7.1 | (7.1) | — | ||||||||||||||||||||||
Shipping and handling cost | 274.9 | 16.4 | — | 291.3 | ||||||||||||||||||||||
Operating earnings (loss)(2)(3) | 141.9 | 12.8 | (79.5) | 75.2 | ||||||||||||||||||||||
Depreciation, depletion and amortization | 42.9 | 24.6 | 5.2 | 72.7 |